v3.25.4
Fourth Quarter Financial Results (unaudited)
12 Months Ended
Dec. 31, 2025
Quarterly Financial Information Disclosure [Abstract]  
Fourth Quarter Financial Results (unaudited) Fourth Quarter Financial Results (unaudited)
quarter ended December 31 (in millions except per share data)2025
Net revenues$16,618 
Gross margin12,066 
Net earnings attributable to AbbVie Inc.
1,816 
Basic earnings per share attributable to AbbVie Inc.$1.02 
Diluted earnings per share attributable to AbbVie Inc.$1.02 
Cash dividends declared per common share$1.73